Literature DB >> 4047346

Ophthalmological, psychometric and therapeutic investigation in two sisters with hereditary glutathione synthetase deficiency (5-oxoprolinuria).

A Larsson, L Wachtmeister, L von Wendt, R Andersson, L Hagenfeldt, K M Herrin.   

Abstract

Two sisters with hereditary glutathione synthetase deficiency (5-oxoprolinuria) were investigated. Assays of erythrocyte enzyme levels in relatives revealed additional clinically healthy carriers. The girls had chronic metabolic acidosis, which was corrected by substitution with bicarbonate. They had an increased rate of hemolysis which was well compensated. Their granulocyte function was normal when tested in vitro. In both girls mental retardation developed progressively without additional clinical neurological symptoms. Their electroretinograms were abnormal indicating disturbed retinal electrophysiological function. Therapeutic trials were performed with oral administration of glutathione (Tathion), mercaptopropionylglycine (Thiola) and vitamin E. None of these compounds had an effect on the urinary excretion of 5-oxoproline, acid-base balance, pathological electroretinograms or the clinical condition. Initially, Thiola therapy increased the low levels of glutathione in patient erythrocytes but after several months of treatment the concentration of glutathione declined to pretreatment levels. There was no indication that orally administered glutathione, mercaptopropionylglycine or vitamin E had a beneficial effect in the doses used. Nevertheless, vitamin E administration has been continued in addition to the correction of acidosis with sodium bicarbonate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4047346     DOI: 10.1055/s-2008-1052557

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

1.  Acute administration of 5-oxoproline induces oxidative damage to lipids and proteins and impairs antioxidant defenses in cerebral cortex and cerebellum of young rats.

Authors:  Carolina Didonet Pederzolli; Caroline Paula Mescka; Bernardo Remuzzi Zandoná; Daniella de Moura Coelho; Angela Malysz Sgaravatti; Mirian Bonaldi Sgarbi; Angela Terezinha de Souza Wyse; Clóvis Milton Duval Wannmacher; Moacir Wajner; Carmen Regla Vargas; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

2.  L-pyroglutamic acid inhibits energy production and lipid synthesis in cerebral cortex of young rats in vitro.

Authors:  A R Silva; C G Silva; C Ruschel; C Helegda; A T Wyse; C M Wannmacher; M Wajner; C S Dutra-Filho
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

3.  A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria).

Authors:  J Mårtensson; J Gustafsson; A Larsson
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  5-Oxoproline reduces non-enzymatic antioxidant defenses in vitro in rat brain.

Authors:  Carolina D Pederzolli; Angela M Sgaravatti; César A Braum; Cristina C Prestes; Giovanni K Zorzi; Mirian B Sgarbi; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2007-01-20       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.